Skip to main content
OpenTrials
Completed

NCT Number: NCT04896502

Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers

The study is about comparing asthma home assessments/interventions by telemedicine compared to providing education alone. Interactive Video (IAV) defines telemedicine. It allows two-way communication in real-time with both audio and visual communication between the subject and someone from the study team. It is similar to using Face Time on a mobile device. Asthma home assessments/interventions are used to identify things in a home that can make asthma symptoms worse, called triggers. Reducing these triggers in the home can improve asthma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States

About this study

In this study, supplies will be given to some participants to help reduce or remove triggers from the home. One example is dust mites. These are microscopic bugs that are found in every home, cannot be seen by the naked eye, and make asthma symptoms worse. Part of the study includes collecting two dust samples from home to check dust mite levels at the beginning of the study and at the end. This study may help elucidate whether telemedicine home assessments work better than education alone at lowering dust mite levels and improving a child's asthma symptoms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 5 years and ≤ 18 years
  • Have a diagnosis of persistent asthma as defined by national guidelines criteria1
  • Patient receives care in Arkansas Children's Hospital (ACH) primary care, in patient and/or specialty clinics
  • Patient has had at least one or more acute exacerbations of asthma within the 12 months prior to enrollment that led to an emergency department visit, hospital admission, or prescription for systemic steroids
  • English speaking participants/parents
  • Access to WIFI, smartphone or mobile device (tablet)

Exclusion criteria

  • Age <5 or >18 years
  • Non-English speaking participants/parents
  • Patients not receiving primary and/or asthma specialty care or inpatient services at ACH
  • Inability of patient or family to participate in TM evaluation due to lack of access to WIFI or smartphone or mobile device

Treatment and study plan

Standard of care education

Behavioral

Education regarding recognition and removal of in-home asthma triggers

Interactive Video (IAV) Telemedicine

Other

Interactive video assessment of asthma triggers in the home.

Primary outcomes

  1. Number of Subjects With a Significant Change in D. Pteronyssinus Levels at End of Study Evaluation

    Time frame: 4 months

    Comparison of D. pteronyssinus levels collected in participant homes at baseline and at end of study with measure of number of subjects with a significant change

Secondary outcomes

  1. Differences in ACT Score Between Telemedicine and Standard of Care Groups

    Time frame: 6 months

    We will measure differences in ACT scores from baseline to 6 months between the Telemedicine and Standard of Care groups. Asthma Control Test (ACT) is a 5 question (<12 years of age) or 7 question (>/= 12 years of age) test utilized to assess asthma control. Scores range from 0 to 25. The maximum score is 25 and a score of 19 or less indicates "not well-controlled" asthma.

  2. Patient Satisfaction

    Time frame: 6 months

    Patient satisfaction measured by standardized survey. Respondents were asked "How satisfied were you with your overall experience?" and were scored on a scale from "Complete Satisfied" to "Not at All Satisfied"

Sponsors and collaborators

Lead sponsor

University of Arkansas

Other

Registry information

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
May 21, 2021
Registry last updated
Oct 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.